
Snotrax S 250mg/125mg Injection
Marketer
Ausler Snovy Pharma
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Snotrax S 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curtailing infection spread. Administration must be strictly under medical guidance; adherence to the prescribed schedule is crucial. Complete the entire course, regardless of symptom improvement; premature cessation may compromise efficacy. Commonly reported adverse effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require prompt emergency care. Prior to commencing treatment, disclose all current medications to your physician. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to potential increased somnolence. While generally non-impairing, driving should be avoided if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and sufficient hydration promote optimal recovery. Monitoring may involve periodic laboratory assessments to evaluate therapeutic response.
Uses of Snotrax S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Snotrax S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Snotrax S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Snotrax S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Snotrax S 250mg/125mg Injection works:
Snotrax S, a 250mg/125mg injectable solution, unites Ceftriaxone, a bacterial growth inhibitor, and Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Sulbactam augments Ceftriaxone's efficacy by countering bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Snotrax S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Snotrax S, 250mg/125mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; clinical data from human trials, however, remain scarce.
Breast feedingCAUTION
Administering Snotrax S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Snotrax S 250mg/125mg Injection might cause drowsiness, blurred vision, and dizziness. Refrain from operating vehicles should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Snotrax S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Snotrax S 250mg/125mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alterations for Snotrax S 250mg/125mg Injection are not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Snotrax S 250mg/125mg Injection :
Should you forget a scheduled dose of Snotrax S 250mg/125mg Injection, seek medical advice.
Facts to Know About Snotrax S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
